Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00017485 · ClinicalTrials.gov registry record · Phase 1
Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
A Phase 1 study of Non-melanomatous Skin Cancer, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT00017485: Completed Phase 1 study of Non-melanomatous Skin Cancer, sponsored by Roswell Park Cancer Institute.
NCT00017485 is a Phase 1 study of Non-melanomatous Skin Cancer that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00017485, a Phase 1 study of Non-melanomatous Skin Cancer, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by cancer cells and, when exposed to light, become active and kill the cancer cells. PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy with HPPH in treating patients who have basal cell skin cancer.
Conditions Studied
Interventions
- DRUG HPPH
Study Locations (1)
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2000-01 |
| Est. Completion | 2007-01 |
| Phase | Phase 1 |
What the finished NCT00017485 record still lists
NCT00017485 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Non-melanomatous Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which HPPH is the first listed.
NCT00017485 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00017485 about?
NCT00017485 is a clinical study titled "Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer". RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photosensitizing drugs such as HPPH are absorbed by cancer cells and, when exposed to light, become active and kill the cancer cells. PURPOSE: Phase I trial to study the effectiv...
What is the current status of trial NCT00017485?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2000-01. Estimated completion is 2007-01.
What conditions does trial NCT00017485 study?
This clinical trial studies the following conditions: Non-melanomatous Skin Cancer.
What interventions are being tested in trial NCT00017485?
The interventions under investigation include: HPPH (DRUG).
Who is sponsoring clinical trial NCT00017485?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00017485 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-melanomatous Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00017485's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia